Skip to main content

Table 1 Summary of reported EGPA patients with occlusion of arteries in the extremities

From: A delayed diagnosis of eosinophilic granulomatosis with polyangiitis complicated with extensive artery occlusion of lower extremities in children: case report and literature review

Author, year

Braunberger T, 2016

Waseda K, 2011

Otani Y, 2003

Inui S, 2001

Abbas MA, 2000

Present study, 2018

Country

USA

Japan

Japan

Japan

UK

China

Sex

Male

Female

Male

Male

Female

Female

Age, years

72

37

59

69

49

10.8

Clinical manifestations

 Asthma

+a

+

+

+

+

+

 Eosinophilia

-b

+

+

+

+

+

 Neuropathy

+

–

+

+

+

+

 Pulmonary

–

–

–

–

+

+

 Skin lesions

+

–

+

+

–

+

Extrapulmonary

Weight loss, fever

Fever

Liver infarction

Atrial fibrillation, fatigue, fever, weight loss

Microhaematuria, proteinuria, arthralgia,

Arthralgia and myalgia

Peak level of eosinophils

Normal

1.9 × 109/L

12.9 × 109/L

15.8 × 109/L

13.1 × 109/L

7.3 × 109/L

ANCAs

Negative

Negative

Negative

Negative

Negative

Negative

Presentation of vasculitis

Occluded right anterior tibial artery

Narrowing of the dorsalis pedis artery and of the peripheral arteries of her right leg

Narrowing of the main arteries in the forearms and lower legs; narrowing and occlusion of the hepatic vein

Stenosis of the medium sized arteries in both legs

Digital vasculitis affecting the left index and middle finger

Extensive stenosis and/or occlusion of shank and foot arteries with formation of collateral vessels

Treatment

CTX, methylprednisolone, maintaining with prednisone

Prednisolone, CSA, CTX, Antithrombotic agents, azathioprine

Prednisolone, intravenous PG1

Prednisolone

Methylprednisolone, CTX

Methylprednisolone maintain with prednisone, methotrexate, antithrombotic agents

Prognosis

Right partial second toe amputation, alive

Plastic surgery, alive

Amputate, alive

Alive

Alive

Alive

  1. Abbreviations: ANCAs antineutrophil cytoplasmic antibodies, including p-ANCA and c-ANCA, CSA cyclosporin A, CTX cyclophosphamide, PG1 prostaglandin E1
  2. aPositive, bNegative